MoneyWorks4Me

Natural Capsules - Quaterly Results

21 May 2024 Evaluate
The revenue zoomed 5.46% to Rs. 402.00 millions for the quarter ended March 2024 as compared to Rs. 381.20 millions during the corresponding quarter last year.Net profit of the cmpany stood at Rs. 16.90 millions for the quarter ended March 2024 a decline of -49.85% from Rs. 33.70 millions  in the same quarter last year.A decline of 57.70 millions was observed in the OP in the quarter ended March 2024 from 76.90 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 402.00 381.20 5.46 1538.10 1728.70 -11.03 1538.10 1728.70 -11.03
Other Income 12.60 8.10 55.56 31.40 10.60 196.23 31.40 10.60 196.23
PBIDT 57.70 76.90 -24.97 239.10 365.00 -34.49 239.10 365.00 -34.49
Interest 13.80 12.70 8.66 49.50 35.60 39.04 49.50 35.60 39.04
PBDT 43.90 64.20 -31.62 189.60 329.40 -42.44 189.60 329.40 -42.44
Depreciation 21.40 18.60 15.05 85.70 72.00 19.03 85.70 72.00 19.03
PBT 22.50 45.60 -50.66 103.90 257.40 -59.63 103.90 257.40 -59.63
TAX 5.60 11.90 -52.94 25.90 65.40 -60.40 25.90 65.40 -60.40
Deferred Tax 2.30 6.40 -64.06 6.20 10.90 -43.12 6.20 10.90 -43.12
PAT 16.90 33.70 -49.85 78.00 192.00 -59.38 78.00 192.00 -59.38
Equity 93.30 92.80 0.54 93.30 92.80 0.54 93.30 92.80 0.54
PBIDTM(%) 14.35 20.17 -28.85 15.55 21.11 -26.38 15.55 21.11 -26.38
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..